B6.Cg-Tg(Bmx-cre/ERT2)1Rha/H
Status | Available to order |
EMMA ID | EM:15026 |
International strain name | B6.Cg-Tg(Bmx-cre/ERT2)1Rha/H |
Alternative name | C57BL/6J-Tg(Bmx-cre/ERT2)1Rha |
Strain type | Transgenic Strains |
Allele/Transgene symbol | Tg(Bmx-cre/ERT2)1Rha |
Gene/Transgene symbol | Tg(Bmx-cre/ERT2)1Rha |
Information from provider
Provider | Ralph H Adams |
Provider affiliation | Max Planck Institute for Molecular Biomedicine |
Genetic information | An inducible cre deleter under the control of the BMX non-receptor tyrosine kinase promoter; cre recombination is inducible via administration of tamoxifen. Useful for study of angiogenesis, atherosclerosis and neovascularization. Non-induced Bmx-CreERT2 mice demonstrate no cre recombinase activity, while tamoxifen-induced Bmx-CreERT2 mice demonstrate high levels of recombinase-mediated gene deletion in endothelial cells (95%+). |
Phenotypic information | Homozygous:Not knownHeterozygous:Normal appearance |
Breeding history | Founder lines were backcrossed to C57BL/6 for at least five generations. |
References |
|
Homozygous fertile | not known |
Homozygous viable | not known |
Homozygous matings required | no |
Immunocompromised | no |
Information from EMMA
Archiving centre | Mary Lyon Centre at MRC Harwell, Oxford, United Kingdom |
Literature references
- Notch controls retinal blood vessel maturation and quiescence.;Ehling Manuel, Adams Susanne, Benedito Rui, Adams Ralf H, ;2013;Development (Cambridge, England);140;3051-61; 23785053
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).